Confirm the presence of BRAF V600E mutation in tumor specimens prior to initiation of treatment with Dabrafenib.
The recommended dose for Dabrafenib is 150 mg orally taken twice daily, approximately 12 hours apart, until disease progression or unacceptable toxicity occurs. Take either at least 1 hour before or at least 2 hours after a meal.
A missed dose can be taken up to 6 hours prior to the next dose. Do not open, crush, or break Dabrafenib capsule.
For New Primary Cutaneous Malignancies: No dose modifications are recommended.
from FDA,2013.05
Dabrafenib is a targeted therapy that has demonstrated significant therapeutic p···【more】
Release date:2025-01-13Recommended:94
Dabrafenib is an important therapeutic drug, and its dosage has attracted much a···【more】
Release date:2025-01-13Recommended:130
Dabrafenib is an important anti-cancer drug, and its correct use is crucial to t···【more】
Release date:2025-01-10Recommended:169
Dabrafenib is a drug used to treat a specific type of cancer, and its correct do···【more】
Release date:2025-01-10Recommended:140